Changsong Qi

1 ta ish

Peking University

1. Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

   Changsong Qi, Chang Liu, Zhi Peng +31

   MaqolaOAOchiq kirish20252 iqtibos

   ABIABI:AkademIndex/2026.other.103004